Hexin Pharmaceutical
Taicang
About Hexin Pharmaceutical
Hexin Pharmaceutical is a developer of nuclide drugs integrating targeted diagnosis and treatment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $14.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2023)
- Website: hexin-med.com
- Phone: 051-25666-8988
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/hexin-pharmaceutical-137129 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.